IPP Bureau
USFDA suggests corrective measures to Sun Pharmaceutical’s Mohali facility
By IPP Bureau - April 24, 2023
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013
By IPP Bureau - April 24, 2023
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Aurisco expands Oligonucleotide capacity
By IPP Bureau - April 24, 2023
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData
By IPP Bureau - April 24, 2023
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Cadila plans an injectable manufacturing facility in collaboration with Russia
By IPP Bureau - April 22, 2023
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
LTS acquires Sorrel wearable injection device business
By IPP Bureau - April 22, 2023
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Sai Life Sciences opens research facility SSRL
By IPP Bureau - April 22, 2023
Fully equipped labs with 75-member team set-up and made operational in <100 days
Ajinomoto Bio-Pharma receives FDA approval for high potency fill line
By IPP Bureau - April 22, 2023
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
CCI approves Berhyanda's acquisition of Suven Pharma
By IPP Bureau - April 22, 2023
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Roquette opens new pharma innovation center in US
By IPP Bureau - April 21, 2023
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
SÜDPACK’s PharmaGuard blister concept to add to sustainability
By IPP Bureau - April 21, 2023
SÜDPACK is setting standards in terms of both performance and sustainability
Ashland diagnostic films medical device facilities achieve ISO certification
By IPP Bureau - April 21, 2023
Gafchromic films support patient care in oncology
Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData
By IPP Bureau - April 21, 2023
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Zydus receives final approval from the USFDA for Metoprolol Tartrate
By IPP Bureau - April 21, 2023
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Takeda showcases digital health solutions at G20 Meeting in India
By IPP Bureau - April 20, 2023
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
